SK286445B6 - Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia - Google Patents

Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia Download PDF

Info

Publication number
SK286445B6
SK286445B6 SK5099-2006A SK50992006A SK286445B6 SK 286445 B6 SK286445 B6 SK 286445B6 SK 50992006 A SK50992006 A SK 50992006A SK 286445 B6 SK286445 B6 SK 286445B6
Authority
SK
Slovakia
Prior art keywords
valnemulin
pigs
group
mic
infection
Prior art date
Application number
SK5099-2006A
Other languages
English (en)
Slovak (sk)
Inventor
David George Sidney Burch
Paul Howard Ripley
Erich Zeisl
Original Assignee
Biochemie Gesellschaft Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614015.7A external-priority patent/GB9614015D0/en
Priority claimed from GBGB9614012.4A external-priority patent/GB9614012D0/en
Priority claimed from GBGB9614019.9A external-priority patent/GB9614019D0/en
Priority claimed from GBGB9614013.2A external-priority patent/GB9614013D0/en
Priority claimed from GBGB9614014.0A external-priority patent/GB9614014D0/en
Priority claimed from GBGB9614018.1A external-priority patent/GB9614018D0/en
Priority claimed from GBGB9614016.5A external-priority patent/GB9614016D0/en
Application filed by Biochemie Gesellschaft Mbh filed Critical Biochemie Gesellschaft Mbh
Publication of SK286445B6 publication Critical patent/SK286445B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK5099-2006A 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia SK286445B6 (sk)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9614017.3A GB9614017D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614015.7A GB9614015D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614012.4A GB9614012D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614019.9A GB9614019D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614013.2A GB9614013D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614014.0A GB9614014D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614018.1A GB9614018D0 (en) 1996-07-04 1996-07-04 Organic compounds
GBGB9614016.5A GB9614016D0 (en) 1996-07-04 1996-07-04 Organic compounds
PCT/EP1997/003518 WO1998001127A1 (en) 1996-07-04 1997-07-03 Veterinary use of a pleuromutilin derivative

Publications (1)

Publication Number Publication Date
SK286445B6 true SK286445B6 (sk) 2008-10-07

Family

ID=27571326

Family Applications (4)

Application Number Title Priority Date Filing Date
SK5099-2006A SK286445B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
SK27-99A SK285711B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
SK5098-2006A SK285857B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
SK5100-2006A SK286431B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia

Family Applications After (3)

Application Number Title Priority Date Filing Date
SK27-99A SK285711B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
SK5098-2006A SK285857B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
SK5100-2006A SK286431B6 (sk) 1996-07-04 1997-07-03 Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia

Country Status (25)

Country Link
US (1) US6130250A (bg)
EP (4) EP0910363B1 (bg)
JP (1) JP4165769B2 (bg)
CN (1) CN1121216C (bg)
AT (2) ATE509625T1 (bg)
AU (1) AU718701B2 (bg)
BG (1) BG64369B1 (bg)
BR (1) BR9710208A (bg)
CA (1) CA2256514C (bg)
CZ (4) CZ298445B6 (bg)
DE (1) DE69740162D1 (bg)
DK (2) DK0910363T3 (bg)
ES (2) ES2364414T3 (bg)
GB (1) GB9614017D0 (bg)
HU (1) HU230325B1 (bg)
IL (1) IL127299A (bg)
NO (1) NO326117B1 (bg)
NZ (1) NZ333261A (bg)
OA (1) OA10951A (bg)
PL (1) PL189204B1 (bg)
PT (2) PT1813272E (bg)
RU (1) RU2197237C2 (bg)
SK (4) SK286445B6 (bg)
UA (1) UA56173C2 (bg)
WO (1) WO1998001127A1 (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
TWI228048B (en) * 1999-12-09 2005-02-21 Novartis Ag New formulation
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
US6682762B2 (en) * 2001-10-09 2004-01-27 Heart-O-Dixie Animal Nutrition, Llc Poultry and livestock feed additive
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
EP1686115A1 (de) * 2005-01-26 2006-08-02 Novartis AG Organische Säureadditionssalze von Valnemulin
DE102006021493B4 (de) * 2006-05-09 2010-04-01 Bruker Daltonik Gmbh Massenspektrometrische Messung mikrobieller Resistenzen
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
CN101690717B (zh) * 2009-09-30 2013-03-06 北京大北农动物保健科技有限责任公司 一种兽用沃尼妙林及其盐的预混剂及制备方法
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130709A (en) * 1977-12-08 1978-12-19 Eli Lilly And Company Pleuromutilin glycoside derivatives
US4247542A (en) * 1978-06-22 1981-01-27 Eli Lilly And Company A-40104 Antibiotics and process for production thereof
DE3405632A1 (de) * 1984-02-17 1985-08-22 Sandoz-Patent-GmbH, 7850 Lörrach Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE3560511D1 (en) * 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
AT392272B (de) * 1989-10-03 1991-02-25 Biochemie Gmbh Verfahren zur herstellung eines pleuromutilinderivats und seiner saeureadditionssalze
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
CN1039585C (zh) * 1993-01-01 1998-08-26 生化企业 截短侧耳素衍生物与环糊精的配合物和含有它的药物制剂

Also Published As

Publication number Publication date
NO326117B1 (no) 2008-09-29
NO986198L (no) 1998-12-30
EP1813272A1 (en) 2007-08-01
WO1998001127A1 (en) 1998-01-15
AU3692997A (en) 1998-02-02
CA2256514A1 (en) 1998-01-15
CZ298444B6 (cs) 2007-10-03
ES2364414T3 (es) 2011-09-01
CZ298446B6 (cs) 2007-10-03
DK1813272T3 (da) 2011-07-18
OA10951A (en) 2003-02-26
BG64369B1 (bg) 2004-12-30
HUP9903103A3 (en) 2000-04-28
EP0910363A1 (en) 1999-04-28
NO986198D0 (no) 1998-12-30
BR9710208A (pt) 1999-08-10
EP0910363B1 (en) 2011-05-18
GB9614017D0 (en) 1996-09-04
CN1121216C (zh) 2003-09-17
IL127299A0 (en) 1999-09-22
JP2000514072A (ja) 2000-10-24
BG103002A (bg) 1999-09-30
SK285711B6 (sk) 2007-06-07
HUP9903103A2 (hu) 2000-02-28
DE69740162D1 (de) 2011-05-12
AU718701B2 (en) 2000-04-20
CZ298445B6 (cs) 2007-10-03
ATE509625T1 (de) 2011-06-15
CZ438198A3 (cs) 1999-03-17
ATE503475T1 (de) 2011-04-15
EP1810672A1 (en) 2007-07-25
HU230325B1 (hu) 2016-02-29
US6130250A (en) 2000-10-10
SK2799A3 (en) 1999-09-10
NZ333261A (en) 2000-09-29
SK286431B6 (sk) 2008-10-07
CZ298385B6 (cs) 2007-09-19
CN1223576A (zh) 1999-07-21
PT910363E (pt) 2011-05-31
EP1808171A1 (en) 2007-07-18
PL330726A1 (en) 1999-05-24
EP1813272B1 (en) 2011-03-30
JP4165769B2 (ja) 2008-10-15
CA2256514C (en) 2006-11-28
PL189204B1 (pl) 2005-07-29
DK0910363T3 (da) 2011-09-05
IL127299A (en) 2005-05-17
ES2360813T3 (es) 2011-06-09
SK285857B6 (sk) 2007-09-06
PT1813272E (pt) 2011-04-29
UA56173C2 (uk) 2003-05-15
RU2197237C2 (ru) 2003-01-27

Similar Documents

Publication Publication Date Title
Songer The emergence of Clostridium difficile as a pathogen of food animals
Bradley et al. Coccidiosis in chickens: obligate relationship between Eimeria tenella and certain species of cecal microflora in the pathogenesis of the disease
SK286445B6 (sk) Použitie derivátu pleuromutilínu na liečenie veterinárneho ochorenia
Mohammed et al. A review of rabbit diseases in Egypt
US20210378261A1 (en) Novel gras probiotic bacterial strain to inhibit acidosis and liver abscesses in cattle
US20240122953A1 (en) Methods for reducing pathogenic e coli by selective feed additive intervention
Tenk Examination of Mycoplasma bovis infection in cattle
KR100516418B1 (ko) 플루로뮤틸린유도체의수의학적용도
MXPA99000264A (en) Veterinary use of a pleuromutil derivative
Larivière et al. Escherichia coli strains isolated from diarrheic piglets in the Province of Quebec.
TW410221B (en) A pharmaceutical composition for the use in the therapy of a veterinary disease complex caused by increasing stocking density
KR102199186B1 (ko) 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물
KR102177371B1 (ko) 클로르테트라사이클린, 네오마이신 및 로페라마이드를 유효성분으로 포함하는 동물용 항균제 조성물
Palacios-Arriaga et al. Efficacy of florfenicol premix in weaning pigs experimentally infected with Actinobacillus pleuropneumoniae.
Kott Chronological studies of respiratory disease in baby pigs
CN117838851A (zh) 一种猪繁殖与呼吸综合征活疫苗稀释液及其制备方法与应用
Nhi et al. SWINE COLIBACILLOSIS IN PIG
NO331772B1 (no) Veterinaermedisinsk anvendelse av et pleuromutilinderivat
KR20030016802A (ko) 부포린 ⅱ를 포함하는 포유류의 설사증 치료용 조성물

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: NOVARTIS TIERGESUNDHEIT AG, BASEL, CH

Free format text: FORMER OWNER: BIOCHEMIE GESELLSCHAFT MBH, KUNDL, AT

Effective date: 20150604

MK4A Expiry of patent

Expiry date: 20170703